An empirical study should begin with the recipient rather than infer behavior from the national surplus. For corporations, link foreign earnings and distributions to domestic cash flow, debt repayment, capital expenditure and shareholder payouts. For financial institutions, examine income, hedge costs, funding obligations and benefit payments. For households, identify the exposure through direct holdings or intermediaries before estimating spending responses.
A credible corporate comparison would distinguish firms with similar domestic opportunities but different exposure to a foreign-income change. Foreign demand shocks, exchange-rate translation and changes in payout rules are possible sources of variation, but none is automatically exogenous. A firm with expanding foreign operations may also have stronger management or products, making a simple foreign-versus-domestic comparison misleading.
The timing should follow earnings, declaration, payment, conversion and final use. An event study centered only on an earnings announcement can capture information about future profitability rather than an immediate liquidity shock. A study centered on cash receipt can miss anticipated spending. Examining both dates and pre-existing plans helps separate those mechanisms.
Competing explanations should be tested explicitly. If domestic investment remains weak despite larger cash receipts, constrained demand or operating inputs may matter more than finance. If distributions rise but household spending does not, ownership concentration, saving or debt adjustment may explain the difference. If yen conversion remains limited, overseas liquidity management and hedging may be relevant. Each outcome narrows the mechanism without invalidating the entire income account.
A national assessment would then aggregate verified responses with appropriate weights and account for offsets. Domestic spending can raise imports; payouts can be received by nonresident shareholders; retained funds can support future foreign earnings. A partial-equilibrium response at one firm cannot be labeled the national multiplier without those adjustments. The framework permits a disciplined estimate when data support it and an explicit limit when they do not.